Medicenna Therapeutics Corp. Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019
Medicenna Therapeutics Corp. (MDNAF) had Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 of 1.9 CAD/shares as of 2023-03-31, per its 20-F filed 2023-06-27.
Discontinued › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 · last filed 2023-06-27
- 2023-03-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 1.90 CAD/shares.
- 2022-03-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 1.64 CAD/shares.
- 2021-03-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 1.69 CAD/shares.
| Period end | Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 |
|---|---|
| 2023-03-31 | 1.90 CAD/shares 20-F · filed 2023-06-27 |
| 2022-03-31 | 1.64 CAD/shares 20-F · filed 2022-06-22 |
| 2021-03-31 | 1.69 CAD/shares 40-F · filed 2021-05-28 |